MedPath

Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting

Completed
Conditions
Stillbirth
Registration Number
NCT02339077
Lead Sponsor
University of Witwatersrand, South Africa
Brief Summary

This is a descriptive study to determine the role of fetal GBS disease as a cause for stillbirths

Detailed Description

A prospective, descriptive study will be undertaken involving mothers who have a stillbirth at Chris Hani Baragwanath Academic Hospital (CHBAH), a secondary-tertiary care hospital, from 2014 up until 2016.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
354
Inclusion Criteria
  • Pregnant women delivering a stillbirth at CHBAH
  • Participants aged ≥18 years
  • Able to understand and comply with planned study procedures
  • Provides written informed consent (either generic ICF or V98_28OBTP)
Exclusion Criteria
  • Refuses to consent to study participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the number of stillbirths who have GBS isolated from cord blood, gastric aspirates, placenta and/ or skin swabsBirth
Secondary Outcome Measures
NameTimeMethod
Number of stillbirths occurring at CHBAH, and identify potential causes of the stillbirths (maternal and obstetric risk factors)Birth

To determine the epidemiology of stillbirths, including identification of maternal risk-factors

Number of stillbirths related to a probable Infectious causeBirth

To determine the proportion of stillbirths that are associated with common fetal in-utero infections including; Syphilis (Treponema pallidum), Klebsiella sp, E. Coli

Trial Locations

Locations (2)

Chris Hani Baragwanath Academic Hospital

🇿🇦

Johannesburg, Gauteng, South Africa

Respiratory and Meningeal Pathogen Research Unit

🇿🇦

Johannesburg, Gauteng, South Africa

© Copyright 2025. All Rights Reserved by MedPath